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Autophagy is induced in renal tubular cells during acute
kidney injury; however, whether this is protective or injurious
remains controversial. We address this question by
pharmacologic and genetic blockade of autophagy using
mouse models of cisplatin- and ischemia–reperfusion-
induced acute kidney injury. Chloroquine, a pharmacological
inhibitor of autophagy, blocked autophagic flux and
enhanced acute kidney injury in both models. Rapamycin,
however, activated autophagy and protected against
cisplatin-induced acute kidney injury. We also established a
renal proximal tubule–specific autophagy-related gene
7–knockout mouse model shown to be defective in both
basal and cisplatin-induced autophagy in kidneys. Compared
with wild-type littermates, these knockout mice were
markedly more sensitive to cisplatin-induced acute kidney
injury as indicated by renal functional loss, tissue damage,
and apoptosis. Mechanistically, these knockout mice had
heightened activation of p53 and c-Jun N terminal kinase, the
signaling pathways contributing to cisplatin acute kidney
injury. Proximal tubular cells isolated from the knockout mice
were more sensitive to cisplatin-induced apoptosis than cells
from wild-type mice. In addition, the knockout mice were
more sensitive to renal ischemia–reperfusion injury than their
wild-type littermates. Thus, our results establish a
renoprotective role of tubular cell autophagy in acute kidney
injury where it may interfere with cell killing mechanisms.
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Acute kidney injury (AKI) induced by renal ischemia–reper-
fusion, sepsis, and nephrotoxins is a major kidney disease
characterized by rapid loss of renal function, resulting in
accumulation of metabolic wastes and imbalance of electro-
lytes and body fluid. Despite advances in basic research and
medical care during the past several decades, clinical
outcomes of AKI remain poor, with steadily increasing
incidence, unacceptably high mortality, and unsatisfactory
therapeutic approaches.1,2 The pathogenesis of AKI is
multiphasic and multifactorial, involving a complex interplay
between renal tubules, vasculature, and inflammatory
factors.3–6 Pathologically, AKI is characterized by sublethal
and lethal damage of renal tubules, resulting in tubular
dysfunction and cell death in the forms of necrosis and
apoptosis. In this regard, the tubular segments located within
the outer stripe of out medulla, including proximal tubules,
are especially susceptible to injury.3–8
Interestingly, in response to injury, renal tubular cells
activate a myriad of defensive or cytoprotective mechanisms.
For example, stress response genes, such as heat-shock
proteins, are expressed by tubular cells to counteract the
insult.9 p21, a conventional cell cycle regulator, is upregulated
in AKI to antagonize the cell death–promoting action of
cyclin-dependent kinase 2.5 More recently, macroautophagy
(referred to as autophagy hereafter) has been demonstrated
as a stress response of renal tubular cells to acute injury
in vitro and in vivo. Whether autophagy is renoprotective or
injurious remains very controversial.10,11
Autophagy is a cellular process of ‘self-eating’ whereby
cytoplasmic components are sequestered into autophagic
vesicles or vacuoles (called autophagosomes) and then
delivered to lysosomes for degradation.12,13 Recent research
has delineated an evolutionarily conserved molecular machin-
ery of autophagy, which includes a specific class of genes or
proteins called autophagy-related genes, Atgs.12,13 Atgs interact
with each other and other regulatory proteins to form various
protein complexes for the initiation, expansion, and final
maturation of autophagosomes. Deficiency of a specific Atg
leads to inhibition of relevant autophagic events. For example,
Atg7 is a critical regulator of the Atg5–Atg12 and Atg8–phos-
photidylethanolamine conjugation systems in autophagy.
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Accordingly, these conjugations are attenuated in Atg7-null
cells and tissues, resulting in complete blockade of autop-
hagy.14 Functionally, basal or physiological autophagy con-
tributes to the maintenance of cellular homeostasis and quality
control of proteins and subcellular organelles. In pathological
conditions or cell stress, autophagy is induced and may serve
as an adaptive and protective mechanism for cell survival;
however, dysregulated autophagy may also contribute to cell
death.15,16 As a result, autophagy and its deregulation has been
implicated in the pathogenesis of a variety of diseases such as
cancer, neurodegeneration, and heart failure.17
In kidneys, autophagy is essential to the homeostasis and
physiological function of podocytes.18 Notably, autophagy
induction has been demonstrated in renal tubular cells in
experimental models of AKI induced by ischemia–reperfusion
and nephrotoxicants such as cisplatin and cyclosporine.19–26
Tubular autophagy was also detected following unilateral
ureteral obstruction in mice.27 Despite these reports, the
mechanism of autophagy induction during AKI is unclear.
Moreover, the role of autophagy in the pathogenesis of
AKI remains to be debated. Although Chien et al.,19 Suzuki
et al.,20 and Inoue et al.,21 suggested a role of autophagy in
tubular cell death,5 we and others provided evidence for
autophagy as a prosurvival, renoprotective mechanism in
AKI.22–25 Although the cause of the discrepancy is currently
unknown, those studies concluded mainly based on the use
of pharmacological inhibitors of autophagy. Nevertheless,
the latest work by Kimura et al.28 demonstrated heightened
renal ischemia–reperfusion injury in proximal tubule–specific
Atg5-knockout mice, providing the first genetic evidence for
a renoprotective role in an AKI model. In the present study,
we first examined the effect of chloroquine, a pharmacolo-
gical inhibitor of autophagy, on cisplatin-induced AKI. We
further established a renal proximal tubule–specific Atg7-
knockout mouse model and demonstrated the high sensi-
tivity of these mice to both cisplatin-induced AKI and
renal ischemia–reperfusion-induced AKI. Mechanistically,
Atg7-knockout kidney tissues showed heightened activation
of p53 and c-Jun N-terminal kinase (JNK) during cisplatin
treatment, the signaling pathways contributing to tubular cell
death and AKI. In contrast to the aggravating effects of
autophagy inhibition, activation of autophagy by rapamycin
significantly attenuated cisplatin-induced renal injury. Together,
these studies establish a renoprotective role of tubular cell
autophagy in AKI.
RESULTS
Autophagy is induced in proximal tubules during
cisplatin-induced AKI in C57BL/6 mice
We first confirmed the occurrence of autophagy in proximal
tubular cells during cisplatin nephrotoxicity in C57BL/6 mice.
As shown by immunoblot analysis of LC3 in Figure 1a,
cisplatin led to a notable increase of LC3-II in renal cortical and
outer medulla tissues, particularly at days 2 and 3. The LC3-II
accumulation went down at day 4, possibly due to massive
lysosomal degradation of the proteins in autophagosomes
(autophagic flux). Morphologically, the formation of autophago-
somes in kidneys was visualized by immunofluorescence
staining of LC3. In control tissues, LC3 was diffusely
distributed throughout the cells without punctated staining.
Upon cisplatin treatment, intense dot-like LC3 staining puncta
appeared in some renal tubular cells of renal cortex and outer
medulla, indicating the formation of autophagosomes (Figure
1b, LC3). The localization of LC3 puncta was further
determined by costaining with either fluorescein isothiocyanate
(FITC)–labeled phaseolus vulgaris agglutinin (PHA) or peanut
agglutinin, the two lectins that bind proximal and distal
tubular cells, respectively.29 Most of the LC3 puncta colocalized
with the FITC-PHA-positive renal tubules, suggesting that
autophagy was induced mainly in proximal tubular cells by
cisplatin (Figure 1b, FITC-PHA and merge). Quantitatively, on
average, approximately three LC3 dots per proximal tubule
were found in the cisplatin-treated mice, whereas no LC3 dot
was observed in the control mice (Figure 1c). By electron micro-
scopy, our previous work detected the formation of autophagic
vacuoles in proximal tubule cells during cisplatin-induced AKI
in mice. Together, these results demonstrate compelling
evidence for the occurrence of autophagy in this AKI model.
Inhibition of autophagy by chloroquine worsens
cisplatin-induced AKI in C57BL/6 mice
The role of autophagy in the pathogenesis of AKI remains
controversial.19–25 To address this question, we initially
tested the effects of chloroquine, a pharmacological inhibitor
of autophagy, on cisplatin-induced AKI in C57BL/6 mice.
Suppression of autophagic flux by chloroquine was first
confirmed by immunoblot analysis of LC3 and p62. As shown
in Figure 2a and b, at day 4 of cisplatin treatment, LC3-II
induction was not as obvious as the earlier time points of days
2 and 3, probably owing to autolysosomal degradation.
Chloroquine blocked the lysosomal degradation of LC3 in
autophagosomes, leading to a marked accumulation of LC3-II
following cisplatin treatment. As a selective substrate of
autophagy, p62 degradation was also inhibited by chloroquine
(Figure 2a and b), further confirming the inhibitory effect of
chloroquine on autophagy in kidney tissues. We then
examined cisplatin-induced AKI in the absence or presence
of chloroquine. Cisplatin at 25 mg/kg induced moderate AKI
within 3 days as indicated by blood urea nitrogen (BUN)
measurement, which was not affected by chloroquine. At day
4 of cisplatin treatment, BUN level increased to 90 mg/dl,
which was aggravated to 181 mg/dl by chloroquine (Figure
2c). Similarly, serum creatinine was increased from 0.84 to
1.54 mg/dl by chloroquine at day 4 of cisplatin treatment
(Figure 2d). Consistent with the functional data, cisplatin-
induced tissue damage in renal cortex and outer medulla was
aggravated by chloroquine (Figure 2e). Cisplatin treatment led
to the loss of brush border, tubular dilation and distortion,
and cell lysis in some proximal tubules. In the presence of
chloroquine, the majority of the tubules were injured and the
severity of the injury was also increased, showing tubular
disruption and massive tubular lysis with sloughed debris in
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the lumen. Semiquantification confirmed that chloroquine
significantly increased kidney tissue damage during cisplatin
treatment (Figure 2f: 1.3 for cisplatin vs. 2.9 for cisplatinþ
chloroquine). Further examination of renal tissues by TUNEL
(TdT-mediated dUTP nick-end labeling) assay showed that
cisplatin-induced tubular cell apoptosis was increased by
chloroquine (Figure 2g and h). As a control, chloroquine
alone did not induce kidney injury in C57BL/6 mice (data not
shown). Collectively, these results demonstrate the inhibitory
effect of chloroquine on cisplatin-induced autophagy and the
aggravating effect of chloroquine on AKI, suggesting a
renoprotective role of autophagy in this disease model.
Creation and characterization of proximal tubule–specific
Atg7-knockout mouse model
To further define the role of tubular cell autophagy in AKI,
we established a conditional knockout mouse model, in
which Atg7 was deleted specifically from renal proximal
tubules in kidneys. Atg7 is critical for the conjugation
events in autophagy.30 Mice bearing the floxed Atg7 alleles
(Atg7flox/flox) were generated by inserting two loxP sites
around exon 14 that encodes the active site cysteine essential
for activation of the conjugation substrates.14 Atg7flox/flox
mice were bred to transgenic mice expressing the Cre
recombinase under the control of a modified PEPCK
promoter (PEPCK-Cre) that directs Cre expression predo-
minantly in kidney proximal tubular cells and marginally in
hepatocytes.31 After the first round of breeding, heterozygous
female progenies (Atg7flox/þXcreX) were obtained and then
crossed with Atg7flox/flox males to generate Atg7flox/floxXcreY
mice with PEPCK-Cre-mediated Atg7 deletion from renal
proximal tubules (PT-Atg7-KO, Figure 3a). As PEPCK-Cre is
linked to X chromosome,31 we only used male mice for the
study to ensure correct genotypes.
To verify the genotypes, three sets of PCR were conducted
for the genomic DNA sample of each mouse. The genotype of
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Figure 1 |Autophagy is induced in proximal tubules during cisplatin nephrotoxicity in C57BL/6 mice. C57BL/6 mice (male, 8–10 weeks
old) were injected with 25mg/kg cisplatin or saline as control. (a) After the indicated time points, kidneys were harvested to collect cortical
and outer medulla tissues for immunoblot analysis of LC3 and b-actin (loading control). For densitometry, the LC3-II signals were divided
by the b-actin signal of the same samples to determine the ratios. (b) At 3 days after treatment, kidneys were collected for
immunofluorescence staining of LC3, fluorescein isothiocyanate (FITC)–labeled phaseolus vulgaris agglutinin (PHA), and Hoechst 33342
(original magnification  630). Arrows point to LC3 puncta (autophagosomes) and insets show LC3 puncta at a higher magnification.
(c) Quantification of LC3 dots in individual proximal tubule of the cisplatin-treated group. Data are expressed as mean±s.d. Control tissues
did not show LC3 dots.
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Figure 2 | Inhibition of autophagy by chloroquine worsens cisplatin-acute kidney injury (AKI) in C57BL/6 mice. C57BL/6 mice (male,
8–10 weeks old, littermates or age-matched nonlittermates) were divided into three groups for the following treatments, respectively:
(1) saline control (n¼ 3); (2) cisplatinþ saline (n¼ 4); and (3) cisplatinþ chloroquine (n¼ 5). The mice were killed on day 4. (a) Whole-tissue
lysate of kidney cortex was collected for immunoblot analysis of LC3, p62, and b-actin. (b) Densitometry of LC3-II and p62 signals. The blot
in a was analyzed by densitometry. The LC3-II and p62 signals were divided by the b-actin signal of the same samples to determine
the ratios. Data are expressed as mean±s.d. *Po0.05, significantly different from the control group; #Po0.05, significantly different from
the cisplatinþ saline group. (c, d) Blood samples were collected for measurements of blood urea nitrogen (BUN) and serum creatinine
levels. Data are expressed as mean±s.d. *Po0.05, significantly different from the control (or day 0) group; #Po0.05, significantly
different from the cisplatin (CP)þ saline group. (e) Representative histology of kidney cortex (hematoxylin–eosin (H–E) staining, original
magnification  200). (f) Pathological score of tubular damage in cisplatinþ saline and cisplatinþ chloroquine groups. (g) Representative
images of TUNEL (TdT-mediated dUTP nick-end labeling) staining (original magnification  200). (h) Quantification of TUNEL-positive
cells in cisplatinþ saline and cisplatinþ chloroquine groups. Data in f and h are expressed as mean±s.d. *Po0.05, significantly different
from the cisplatinþ saline group. Control tissues without cisplatin treatment did not show tubular damage or apoptotic cells.
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PT-Atg7-KO mice was indicated by the amplification of the
B500-bp fragment of the floxed allele, the nonamplification
of the B600-bp fragment of the wild-type allele, and the
amplification of the B370-bp fragment of the Cre gene
(Figure 3b, lanes 3 and 5). The absence of the Cre gene ensured
the genotype of wild-type (PT-Atg7-WT) mice (Figure 3b,
lanes 1, 2, 4, and 6). By immunoblot analysis of the tissues
from kidney cortex and outer medulla that consist mainly of
proximal tubules, we confirmed that Atg7 expression was
indeed reduced in PT-Atg7-KO mice, compared with their
wild-type littermates (Figure 3c for littermate tissue com-
parison: lanes 2 vs. 1, 4 vs. 3, and 6 vs. 5). We further verified
the PT-Atg7-KO model functionally. To this end, we first
analyzed the Atg7-mediated autophagic conjugations in
collected kidney tissues. In wild-type tissues, LC3-II, the
phosphatidylethanolamine-conjugated form of LC3, was
mainly detected (Figure 3c, lanes 1, 3, and 5); however, in
PT-Atg7-KO tissues, large amount of LC3-I accumulated,
whereas LC3-II was barely detectable (Figure 3c, lanes 2, 4,
and 6). Furthermore, wild-type kidney tissues showed high
levels of Atg5–Atg12 conjugation, which was markedly
reduced in PT-Atg7-KO tissues (Figure 3c, lanes 1, 3, and 5
vs. lanes 2, 4, and 6). In addition, we examined kidney tissues
for the expression and localization of p62, a selective sub-
strate of autophagy. Immunoblot analysis demonstrated
markedly higher p62 in PT-Atg7-KO kidney tissues than
wild type (Figure 3c, lanes 2, 4, and 6 vs. lanes 1, 3, and 5). By
immunohistochemistry, positive p62 staining was detected in
PT-Atg7-KO kidney tissues, and not in wild-type tissues
(Figure 3d). Notably, p62 staining in PT-Atg7-KO tissues
appeared as unevenly distributed cytoplasmic puncta of
various sizes, characteristic of the inclusion bodies seen in
autophagy-deficient cells.32 By morphology, the p62 staining
appeared exclusively in proximal tubules. It is noteworthy
that p62 staining did not show a general increase in all
proximal tubular cells, suggesting that the basal level of
autophagy varies in different tubular cells. Together, these
studies validate the PT-Atg7-KO model, in which Atg7 is
specifically deleted from proximal tubular cells in kidneys.
Cisplatin-induced autophagy is inhibited in renal proximal
tubules in PT-Atg7-KO mice
After verifying the autophagic defects in proximal tubules of
PT-Atg7-KO mice under unchallenged conditions, we further
examined autophagy during cisplatin treatment. As shown in
Figure 4a, in response to cisplatin treatment, wild-type
kidney tissues showed LC3-II accumulation, whereas the
conversion of LC3-I to LC3-II was completely abrogated in
PT-Atg7-KO kidneys. Atg5–Atg12 conjugation was also
reduced in PT-Atg7-KO tissues. Consistent with Figure 3,
the basal level of p62 was significantly higher in PT-Atg7-KO
tissues than wild-type tissues, and following cisplatin
treatment p62 increased markedly (Figure 4a, PT-Atg7-KO).
The effect of Atg7 deficiency on cisplatin-induced autophagy
in proximal tubules was then determined morphologically by
coimmunostaining of LC3 and FITC-labeled PHA. As shown
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Figure 3 |Creation and characterization of the PT-Atg7-KO mouse model. (a) Breeding protocol for generating PT-Atg7-KO mice. Male
littermate mice of 8–9 weeks old were used for experiments after genotypes were confirmed. (b) Representative images of PCR-based
genotyping. Genomic DNA was extracted from tail biopsy and amplified to detect wild-type (WT) and floxed alleles of Atg7 and PEPCK-Cre
allele as indicated. (c) Whole-tissue lysate of kidney cortex was collected from PT-Atg7-KO and wild-type (PT-Atg7-WT) littermate mice for
immunoblot analysis of Atg7, LC3, Atg5 (Atg12 conjugated), p62, and b-actin. (d) Immunohistochemical staining of p62 (original
magnification  200) in kidney cortical tissues of wild-type and PT-Atg7-KO mice. The selected areas were shown at high magnification in
the middle panels.
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in Figure 4b, punctuate or granular LC3 staining was detected
in some proximal tubular cells of wild-type kidneys during
cisplatin treatment, which was barely seen in PT-Atg7-KO
tissues. The number of LC3 puncta per proximal tubule was
significantly reduced from 3.2 in wild-type mice to 0.1 in PT-
Atg7-KO tissues (Figure 4c). By immunohistochemistry, we
found that, compared with the control, cisplatin induced
massive p62 accumulation in proximal tubules in PT-Atg7-
KO mice, as indicated by remarkably increased amount and
size of cytoplasmic p62 inclusion bodies (Figure 4d, high-
magnification inserts). In wild-type tissues, there was an
increase in p62 staining in some proximal tubular cells after
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Figure 4 |Cisplatin-induced autophagy is inhibited in renal proximal tubules in PT-Atg7-KO mice. Wild-type and PT-Atg7-KO mice
were injected with 25mg/kg cisplatin or saline as control. (a) After the indicated time points, kidneys were harvested to collect cortical
tissues for immunoblot analysis of Atg7, LC3, Atg5 (Atg12 conjugated), p62, and b-actin. (b) At 3 days after injection, kidneys were collected
for immunofluorescence staining of LC3, fluorescein isothiocyanate (FITC)-labeled phaseolus vulgaris agglutinin (PHA), and Hoechst
33342 (original magnification  630). Representative images of cisplatin-treated wild-type and PT-Atg7-KO groups were shown. Arrows
point to LC3 dots (autophagosomes) and inset shows LC3 dots at higher magnifications. (c) Quantification of LC3 dots in individual proximal
tubule of cisplatin-treated wild-type and PT-Atg7-KO groups. Data are expressed as mean±s.d. *Po0.05, significantly different from
the wild-type group. (d) After 4 days of treatment, kidneys were collected for immunohistochemical staining of p62 (original magnification
 200). The selected areas are shown at high magnifications.
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cisplatin treatment, but in general the staining was diffuse and
not indicative of inclusion bodies (Figure 4d). Together, these
results suggest that cisplatin-induced autophagy is suppressed
in renal proximal tubular cells in PT-Atg7-KO mice.
Cisplatin-induced AKI is aggravated in PT-Atg7-KO mice
By using the PT-Atg7-KO model, we then determined the role
of autophagy on cisplatin-induced AKI. Without treatment,
both PT-Atg7-KO mice and their wild-type littermates
showed similarly low levels of BUN and serum creatinine,
indicating normal renal function. At 4 days after cisplatin
injection, wild-type mice developed moderate renal failure,
with BUN and serum creatinine levels increased to 151 and
0.74 mg/dl, respectively. In the same experiments, PT-Atg7-
KO mice had more severe loss of renal function, showing
BUN level of 198 mg/dl and serum creatinine level of 1.21 mg/dl
(Figure 5a and b). Notably, the progression of AKI was
accelerated thereafter in PT-Atg7-KO mice. At 5 days after
cisplatin treatment, these mice had 351 mg/dl BUN and
3.24 mg/dl serum creatinine levels, whereas their wild-type
littermates had 244 mg/dl BUN and 1.15 mg/dl serum
creatinine levels (Figure 5a and b). Histological analysis
confirmed that, compared with wild type, cisplatin induced
much more severe kidney tissue damage in PT-Atg7-KO mice,
which showed widespread, extensively damaged proximal
tubules in the renal cortex and outer medulla (Figure 5c).
These tissues had a tubular damage score of 2.2, whereas the
score was 1.3 for wild-type tissues (Figure 5d). Further
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Figure 5 |Cisplatin-acute kidney injury (AKI) is aggravated in PT-Atg7-KO mice. Wild-type (n¼ 15) and PT-Atg7-KO littermate mice
(n¼ 21) were injected with 25mg/kg cisplatin or saline as control. (a, b) Blood samples were collected for measurements of blood urea
nitrogen (BUN) and serum creatinine levels. Data are expressed as mean±s.d. *Po0.05, significantly different from the control (or day 0)
groups; #Po0.05, significantly different from the relevant wild-type group. (c) Representative histology of kidney cortex (hematoxylin–eosin
(H–E) staining, original magnification  200). (d) Pathological score of tubular damage in cisplatin-treated wild-type and PT-Atg7-KO mice.
(e) Representative images of TUNEL (TdT-mediated dUTP nick-end labeling) staining (original magnification  200). (f) Quantification of
TUNEL-positive cells in cisplatin-treated wild-type and PT-Atg7 KO groups. Data in d and f are expressed as mean±s.d. *Po0.05,
significantly different from the wild-type group.
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examination by TUNEL assay indicated that cisplatin induced
significantly more apoptosis in kidney tissues of PT-Atg7-KO
mice than wild-type littermates (Figure 5e and f). Together
with the results of the chloroquine effect (Figure 2), these
studies demonstrate compelling evidence for a renoprotective
role of autophagy against cisplatin-induced AKI.
Heightened p53 and JNK activation during cisplatin
treatment in PT-Atg7-KO mice
The pathogenesis of cisplatin-AKI is very complex, involving
tubular damage, vascular alteration, and a rapid and lasting
inflammatory response.4,5,33 The intrinsic mechanism of
tubular cell death involves the activation of and interplay
between multiple signaling pathways including p53 and
mitogen-activated protein kinases.4,5,34 To gain initial in-
sights into the mechanisms by which autophagy protects
renal tubular cells, we first determined whether p53 signaling
was affected in Atg7-deficient mice. Consistent with previous
reports,35,36 cisplatin induced p53 accumulation and phos-
phorylation in kidney tissues in wild-type mice (Figure 6a,
lanes 1–7). Notably, significantly higher p53 activation was
demonstrated in PT-Atg7-KO tissues (Figure 6a, lanes 8–14).
In line with this observation, the induction of p21 (a
transcription target of p53) was induced by cisplatin in wild-
type tissues, and the induction was much more pronounced
in PT-Atg7-KO tissues (Figure 6a). Densitometric analysis
showed that cisplatin induced 2.6- and 8-fold increases in
total and phosphorylated p53 in wild-type kidney tissues, and
4.5- and 20-fold increases in PT-Atg7-KO tissues, respectively
(Figure 6b). The results suggest that autophagy may interfere
with p53 activation during cisplatin-AKI. It is noteworthy
that p21 is induced in AKI as a defensive mechanism for
kidney protection,5 and the induction is often positively
correlated with the severity of AKI. Consistently, in our study,
cisplatin induced much more severe AKI and markedly
higher p21 in PT-Atg7-KO mice than that in wild-type mice.
We further determined the effect of autophagy deficiency
on mitogen-activated protein kinases, another important
signaling pathway in cisplatin-AKI.4,5 Cisplatin induced
similar levels of extracellular signal–regulated kinase phos-
phorylation in wild-type and PT-Atg7-KO kidney tissues
(Figure 6c and d). However, JNK phosphorylation was
induced to higher levels in PT-Atg7-KO kidney tissues than
wild-type tissues (Figure 6c and d). Interestingly, the changes
of p38 were detected at both phosphorylation and total
protein levels. PT-Atg7-KO kidney tissues showed higher
total p38 expression than wild-type tissues. After cisplatin
treatment, there was a consistent increase of total p38 in
wild-type, but not PT-Atg7-KO, tissues (Figure 6c, p38).
Similarly, phosphorylated p38 was higher in PT-Atg7-KO
tissues under control condition, and after cisplatin treatment
p-p38 increased in wild-type tissues but not in PT-Atg7-KO
tissues. The results suggest that autophagy may affect
mitogen-activated protein kinases, especially JNK, to protect
against cisplatin-AKI.
Increased sensitivity of Atg7-deficient proximal tubular
cells to cisplatin-induced apoptosis
To complement the in vivo study, we examined cisplatin-
induced apoptosis in primary cultures of proximal tubular
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cells isolated from PT-Atg7-KO and wild-type mice. As shown
in Figure 7a, apoptosis was minimal under control conditions
regardless of the status of Atg7. After 24 h of cisplatin
treatment, some cells underwent apoptosis, showing the
typical morphological changes including cellular shrinkage,
and formation of apoptotic bodies (Figure 7a, upper panels).
Nuclear staining with Hoechst 33342 also showed nuclear
condensation and fragmentation in these cells (Figure 7a,
lower panels). Importantly, apoptosis was obviously higher in
Atg7-KO tubular cells (Figure 7a). Quantification by cell
counting showed that cisplatin induced B28% apoptosis in
wild-type cells, but B49% in Atg7-KO cells (Figure 7b). The
morphological results were confirmed by caspase activity
measurement. As shown in Figure 7c, caspase activation
induced by cisplatin was increased from 7.1 nmol/mg/h in
wild-type cells to 12.7 nmol/mg/h in Atg7-KO cells. Thus,
proximal tubular cells isolated from PT-Atg7-KO mice were
more sensitive to cisplatin-induced apoptosis, further support-
ing the in vivo study for a renoprotective role of autophagy.
PT-Atg7-KO mice are more sensitive to ischemic AKI
Although this study focused on cisplatin-induced kidney
injury, our previous work using pharmacological autophagy
inhibitors22 and the latest study by Kimura et al.28 using a
proximal tubule–specific Atg5-knockout mouse model have
suggested that autophagy is renoprotective in ischemic AKI.
We further verified these findings using the PT-Atg7-KO
model. To this end, 25 min of bilateral renal ischemia was
induced in PT-Atg7-KO mice and their wild-type littermates.
AKI was monitored by measuring BUN and serum creatinine
levels at different time points of reperfusion. As shown in
Figure 8a, at 24 h following reperfusion, PT-Atg7-KO mice
had the BUN level of 110 mg/dl, which was significantly
higher than the BUN level of 84 mg/dl in wild-type mice. It is
noteworthy that 25 min of ischemia induced moderate AKI
that was reversible, and as a result both wild-type and PT-
Atg7-KO mice displayed recovery of renal function after
initial injury. On 72 h of reperfusion, BUN level went down
to 54 mg/dl in wild-type mice, whereas PT-Atg7-KO mice
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maintained BUN level at a higher level of 79 mg/dl
(Figure 8a). Consistently, PT-Atg7-KO mice also showed
significantly higher serum creatinine level at 72 h of reperfu-
sion than their wild-type littermates (Figure 8b). Therefore,
both cisplatin- and ischemia–reperfusion-induced AKI were
aggravated in PT-Atg7-KO mice, demonstrating a renopro-
tective role of tubular autophagy in AKI.
Activation of autophagy by rapamycin reduces
cisplatin-induced AKI in C57BL/6 mice
To complement the autophagy inhibitory studies, we tested
the effects of autophagy activation on cisplatin-induced AKI
in C57BL/6 mice. First, we examined whether rapamycin, a
pharmacological inhibitor of the mammalian target of
rapamycin, could enhance autophagy in kidneys during
cisplatin treatment. As shown in Figure 9a, LC3-II increased
in renal cortical tissues 2 days after cisplatin injection. This
accumulation was further increased by rapamycin, suggesting
an enhancement of cisplatin-induced autophagy. We then
compared renal function loss and tissue damage in the
absence and presence of rapamycin. Cisplatin led BUN level
to increase to 168 mg/dl at day 4, which was partially but
significantly reduced to 133 mg/dl by rapamycin (Figure 9b).
Serum creatinine was also decreased from 1.06 mg/dl in the
cisplatin-treated mice to 0.76 mg/dl in the mice treated with
cisplatinþ rapamycin (Figure 9c). Consistently, rapamycin
ameliorated cisplatin-induced tubular damage in renal cortex
and outer medulla, as indicated by histological examination
(Figure 9d). The tubular damage score was 2.7 for the
cisplatin group and 1.9 for the cisplatinþ rapamycin group
(Figure 9e). Together, these results suggest that enhancement
of autophagy by rapamycin may protect against cisplatin-
induced AKI, providing further support for the renoprotec-
tive role of autophagy in kidneys.
DISCUSSION
The role of autophagy in AKI remains controversial.
Although we and others provided evidence for a renopro-
tective role of autophagy in AKI,22–25 there are several reports
supporting a role of autophagy in tubular cell death in the
disease condition.19–21 It is noteworthy that these studies
mainly used in vitro cell culture models or in vivo models
testing pharmacological autophagy inhibitors. The latest
work by Kimura et al.28 demonstrated heightened renal
ischemia–reperfusion injury in proximal tubule–specific
Atg5-knockout mice, providing the first in vivo genetic
evidence for a renoprotective role in this AKI model. Our
present study has used both pharmacologic and genetic
approaches to determine the role of autophagy in ischemic,
as well as cisplatin nephrotoxic, AKI. The results show that
inhibition of autophagy by chloroquine or conditional Atg7
ablation from proximal tubules aggravates AKI, whereas
activation of autophagy by rapamycin protects against AKI.
Collectively, these in vivo pharmacological and conditional
knockout studies have demonstrated the definitive evidence
for a renoprotective role of autophagy in both ischemic and
nephrotoxic AKI.
Conditional knockout of Atg7 in liver and brain affects
development, anatomy, histology, and function of the organs
and even life span of the animals.14,37,38 Nevertheless, the renal
proximal tubule–specific Atg7-knockout mice generated in our
study were normal at birth and had no obvious developmental
defects in kidneys. As suggested in our recent work,39 owing to
the late turn-on feature of the PEPCK promoter (3 weeks after
birth), Cre is not expressed in proximal tubules until kidney
development has mostly completed, which may explain the
normal renal development in PT-Atg7-KO mice. At 8–10
weeks, the kidney tissues of PT-Atg7-KO mice were defective
in clearance of protein aggregates, showing increased level of
p62 and accumulation of cytoplasmic inclusion bodies
(Figure 3). However, these mice showed little difference from
their wild-type littermates on body weight, kidney weight/size,
renal histology, and renal function within the age of up to 3
months (Figure 5 and data not shown). Autophagy defects due
to Atg5 deletion in podocytes leads to glomerulopathy and
proteinuria in aging mice.18 Recent studies further demon-
strated that Atg5 knockout from proximal tubules in mice
results in tubular degeneration at late age.28 It would be
interesting to verify the effect of defective autophagy on aging
kidneys in our PT-Atg7-KO model.
In our study, in addition to LC3, p62 was examined to
monitor autophagy induction and flux. As a ubiquitin-
binding protein, p62 is also a selective substrate of autophagy
owing to its direct interaction with LC3 to facilitate
autophagy degradation of ubiquitinated proteins.40 Theoret-
ically, the cellular level of p62 should inversely correlate with
autophagy activity. This was true when wild-type and PT-
Atg7-KO tissues were compared under unchallenged or
control conditions, where PT-Atg7-KO tissues showed p62
accumulation (Figure 3c and d). However, following cisplatin
treatment, autophagy induction in kidney tissues was not
accompanied by p62 decrease, but instead, it accumulated
(Figures 2a, 4a and d). The p62 accumulation was not caused
by cessation of autolysosomal degradation, because autopha-
gic flux during cisplatin treatment was efficient as indicated
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by the effect of chloroquine that further increased LC3-II and
p62 (Figure 2a). It is noteworthy that in immunohistochem-
istry cisplatin-induced p62 staining in wild-type tissues was
different from that of PT-Atg7-KO tissues with impaired
autophagy. In PT-Atg7-KO tissues, p62 accumulated as
cytoplasmic inclusion bodies, whereas in wild-type tissues
p62 staining was diffuse and not indicative of inclusion
bodies (Figure 4d). Our interpretation is that p62 accumula-
tion in PT-Atg7-KO tissues results from autophagic defects,
whereas cisplatin-induced p62 accumulation in wild-type
tissues may be a result of increased p62 expression and/or
decreased proteasomal degradation of p62. It has been shown
that p62 participates in proteasomal degradation, and its
level may also increase when the proteasome pathway is
inhibited.41,42 In addition, p62 may be transcriptionally
upregulated under certain conditions.43
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The mechanism underlying the cytoprotective effect of
autophagy remains unclear. Generally, we can envision
several possibilities. (1) By digesting cellular constituents,
autophagy generates substrates for ATP production and
protein synthesis that are essential for adaptation to
bioenergetic catastrophe. This occurs during cell starvation.
This possibility is also relevant to ischemic and nephrotoxic
AKI, where the availability of oxygen and nutrient has
decreased and cells experience metabolic stress. (2) Auto-
phagy is an important cellular housekeeping process that
clears misfolded proteins, aggregates, and damaged orga-
nelles. This activity is particularly important for the cells
under stress, in which protein misfolding and aggregation
increase and cellular organelles are damaged. Removal of
these potentially cytotoxic components by autophagy there-
fore provides a protective mechanism for cell survival. In this
regard, damaged mitochondria and abnormal protein
aggregates were shown in Atg5-knockout proximal tubular
cells in mouse kidneys.28 (3) Autophagy may interfere with or
compromise the cell death signaling pathways. This possibil-
ity is best illustrated by the action of Beclin-1 (also called
Atg6). Beclin-1 is a core protein in the complex of autophagy
induction, but it also interacts with Bcl-2 (B-cell lymphoma
2), a well-known antiapoptotic protein. During autophagy,
Beclin-1 moves into the autophagy induction complex and
dissociates from Bcl-2, resulting in the release of Bcl-2 for
cytoprotection.44 Nevertheless, Beclin-1/Bcl-2 interaction was
not verified during cisplatin treatment of renal tubular cells.24
(4) Finally, recent studies have demonstrated that autophagy
can negatively regulate inflammatory response, protecting
cells from ischemic brain injury and endotoxin-induced
intestinal epithelium injury in vivo.45,46 In our present study,
we have examined the effects of autophagy on p53 and
mitogen-activated protein kinases, the two signaling path-
ways contributing to tubular cell apoptosis during cisplatin-
AKI.4,5,34 We demonstrated a heightened activation of p53
and JNK during cisplatin-AKI in PT-Atg7-KO tissues, which
is consistent with the aggravated kidney injury in these
animals (Figure 6). Interestingly, compared with wild-type
kidneys, PT-Atg7-KO tissues had higher levels of both total
and phosphorylated p38 kinase under control conditions.
Following cisplatin treatment, p38 was phosphorylated and
activated in wild-type tissues, but not in PT-Atg7-KO tissues.
Further studies need to gain insights into the molecular
mechanism whereby autophagy modulates these signaling
pathways and protects cells and tissues in disease conditions
such as AKI.
MATERIALS AND METHODS
PT-Atg7-KO mouse model was established by breeding Atg7flox/flox
mice14 with PEPCK-Cre transgenic mice obtained from Dr Volker
Haase (University of Pennsylvania, Philadelphia, PA).31 Genotyping
was performed according to a modified protocol from Dr Zhenyu
Yue (Mount Sinai School of Medicine, New York, NY) and our
recent work.39 Acute kidney injury was induced in mice by cisplatin
and renal ischemia–reperfusion as previously described.22,47 Primary
proximal tubular cells were isolated from mouse kidneys and
cultured as described previously.36 Renal function, histology,
immunohistochemistry, and apoptosis were examined using stan-
dard methods.22,47 Detailed methods including statistical analysis
are described in Supplementary Information online.
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